NAV
$97.20
AUM
$1.2B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.81
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.27% | +2.98% | +3.02% | +14.84% | +15.02% | +8.23% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.63% |
| 2 | NOVN.SW | Novartis AG Registered Shares | 2.18% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.83% |
| 4 | AZN.L | AstraZeneca PLC | 1.79% |
| 5 | NESN.SW | Nestle SA | 1.71% |
| 6 | SHEL.L | Shell PLC | 1.33% |
| 7 | BHP.AX | BHP Group Ltd | 1.16% |
| 8 | TTE.PA | TotalEnergies SE | 1.14% |
| 9 | ULVR.L | Unilever PLC | 1.04% |
| 10 | ZURN.SW | Zurich Insurance Group AG | 0.98% |
The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in depositary receipts based on securities comprising the index. The index captures large- and mid-cap representation across 21 developed market Europe, Australasia, and Far East countries and aims to represent the performance of value, low volatility, and quality factor strategies.
Inception Date: 2014-06-04